Tonix Pharmaceuticals Holding Corp. 8-K

What Happened

• Tonix Pharmaceuticals Holding Corp. announced its operating results for the quarter ended March 31, 2026. The company disclosed the update in a Form 8-K filed May 11, 2026, and included a press release reporting those quarterly results.

Key Details

• Filing date: May 11, 2026 (Form 8-K).
• Item reported: 2.02 — Results of Operations and Financial Condition (operating results for quarter ended March 31, 2026).
• Exhibit: Press Release dated May 11, 2026 is filed as Exhibit 99.01 and is incorporated by reference.
• The report also includes the company’s Inline XBRL cover page (Exhibit 104).

Why It Matters

• Quarterly operating results provide investors with updated information on Tonix’s recent performance (earnings, revenue and cash/expense trends); these figures can affect investor decisions and share price.
• The press release filed with this 8-K contains the detailed financial and operational metrics investors should review to assess the company’s near-term outlook and financial condition.